Vitrolife AB (publ) (LON:0YAY)
London · Delayed Price · Currency is GBP · Price in SEK 117.20
-0.60 (-0.51%)
At close: Feb 2, 2026
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of 1.02 billion as of February 4, 2026. Its market cap has decreased by -49.50% in one year.
Market Cap
1.02B
Enterprise Value
1.09B
Revenue
277.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
117.20
Market Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 33.54M to 1.02B, an increase of 2,941.78%. That is a compound annual growth rate of 14.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.02B | -31.91% |
| Dec 30, 2025 | 1.50B | -28.86% |
| Dec 30, 2024 | 2.11B | 2.64% |
| Dec 29, 2023 | 2.05B | 2.23% |
| Dec 30, 2022 | 2.01B | -67.68% |
| Dec 30, 2021 | 6.21B | 195.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Smith & Nephew | 10.55B |
| Genus | 2.11B |
| HUTCHMED (China) | 1.89B |
| Oxford Nanopore Technologies | 1.50B |
| Oxford Biomedica | 1.00B |